Mumbai, June 4 -- Gland Pharmahas received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Angiotensin II Acetate Injection 2.5 mg/mL.

Published by HT Digital Content Services with permission from Capital Market....